Subjects - Business

Most executives truly believe that they know how to lead effective meetings.

At least that's w

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

hat they'll tell you.

But if you ask a member of their staff, the response may be nervous laug

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ter. Or a cough. Or maybe a letter like this one.

"Years ago I worked for a man who LOVED meet

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ngs. The more we had and the longer they took, the happier he was. I, on the other hand, hate g

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

oing to meetings. Bad meetings are an ENORMOUS, frustrating waste of time.

I lived in San Dieg

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

near my principle office, and all the meetings were held at the regional office in Orange, CA,

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

which was 100 miles door-to-door from my home. So every time he had another long, pointless mee

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ting, I drove 200 miles. Typically, he would open the meetings by saying that he wanted our inp

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

t on this or that; then he'd proceed to spend 2 to 3 to 4 hours telling us what he thought. Onc

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

I sent him a memo telling how much he had paid me that month to sit in my car going to his mee

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ings. I suggested he wasn't getting as much horse power out of my salary as he would if I could

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

actually DO WORK instead of going to these meetings.

His solution: He appointed an ad hoc com

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ittee to meet before our main meetings to discuss the goals and agenda for the meeting to follo

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

. Then this ad hoc committee would stay after the main meeting to discuss what happened and to

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

evaluate the success of the main meeting. So instead of reducing meeting time, he tripled it. A

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

AAAAAAAARRRRRRGGGGGG!

Occasionally out of boredom, I'd look around the conference table at eac

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

participant, speculate on the person's annual salary, and pro-rate it to a half day's meeting.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

I realized that the reason we had financial problems was that we spent all our money on these

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

otten meetings!"

So what are your meetings like?

Do they help you make money or do they cost

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ou money?

Note: Learn more about Effective Meetings at: http://www.squidoo.com/OneGreatMeeting

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/22063/subjects-What-Do-Others-Say-About-Your-Meetings.html">What Do Others Say About Your Meetings?</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/22063/subjects-What-Do-Others-Say-About-Your-Meetings.html]What Do Others Say About Your Meetings?[/url]

Learn the Economic Development, Economic Development Strategy and Business Retention

Name tags are identification materials worn by individuals that display vital information such as name, designation and possibly designs such as logos and other artworks. Name tags industry is a high volume supplies industry catering to the events planning industry such as trade shows, conferences and meetings. The industry supplies identification materials such as tags, badges and plates to professionals, entrepreneurs and media planners.

It is easy to resign badly and to sat things you may regret - read on to find out how you should resign from a job.

Tags

Links

Subjects - What Do Others Say About Your Meetings?

Related Articles: